These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24217677)

  • 21. Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes.
    Parry MG; Nossiter J; Cowling TE; Sujenthiran A; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1196-1203. PubMed ID: 32717261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental changes verses a technological quantum leap: the additional value of intensity-modulated radiotherapy beyond image-guided radiotherapy for prostate irradiation.
    Ratnayake G; Martin J; Plank A; Wong W
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):503-10. PubMed ID: 25243269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced-order parameter optimization for simplifying prostate IMRT planning.
    Lu R; Radke RJ; Happersett L; Yang J; Chui CS; Yorke E; Jackson A
    Phys Med Biol; 2007 Feb; 52(3):849-70. PubMed ID: 17228125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
    Showalter TN; Ohri N; Teti KG; Foley KA; Keith SW; Trabulsi EJ; Lallas CD; Dicker AP; Hoffman-Censits J; Pizzi LT; Gomella LG
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e233-8. PubMed ID: 21605945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Rickles DJ
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
    [No Abstract]   [Full Text] [Related]  

  • 26. National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.
    Sujenthiran A; Nossiter J; Charman SC; Parry M; Dasgupta P; van der Meulen J; Cathcart PJ; Clarke NW; Payne H; Aggarwal A
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1253-1260. PubMed ID: 28974414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-referral in radiation oncology: has caveat emptor replaced primum non nocere?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):874. PubMed ID: 23078893
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of prostate cancer with intensity modulated radiation therapy (IMRT).
    Novaes P; Mottas RT; Lundgren M;
    Rev Assoc Med Bras (1992); 2015; 61(1):8-16. PubMed ID: 25909199
    [No Abstract]   [Full Text] [Related]  

  • 29. [The procedure of intensity-modulated radiotherapy (IMRT) treatment planning for prostate cancer].
    Hanyu Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 Nov; 63(11):1303-9. PubMed ID: 18187915
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensity-modulated radiotherapy in the treatment of prostate cancer.
    Bauman G; Rumble RB; Chen J; Loblaw A; Warde P;
    Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):461-73. PubMed ID: 22673744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.
    Azelie C; Gauthier M; Mirjolet C; Cormier L; Martin E; Peignaux-Casasnovas K; Truc G; Chamois J; Maingon P; Créhange G
    Radiat Oncol; 2012 Sep; 7():158. PubMed ID: 22978763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In regard to Anscher.
    Brezovich IA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1156. PubMed ID: 23517804
    [No Abstract]   [Full Text] [Related]  

  • 33. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
    Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
    Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
    Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
    Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
    Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
    J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a novel dose-uncertainty model for dose-uncertainty analysis in prostate intensity-modulated radiotherapy.
    Jin H; Palta JR; Kim YH; Kim S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):920-8. PubMed ID: 20584579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profit and questions as doctors offer prostate cancer therapy.
    Saul S
    N Y Times Web; 2006 Dec; ():A1, C7. PubMed ID: 17167872
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin JK; Lizarde J; Macedo JC; Ravera J; Tokita KM
    Brachytherapy; 2010; 9(4):341-8. PubMed ID: 19853534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
    Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urologist Practice Structure and Spending for Prostate Cancer Care.
    Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
    Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.